BUZZ-Dexcom rises after quarterly sales beat estimates** Shares of medical device maker Dexcom DXCM.O rise 3.9% to $72.98 premarket
** Late on Thursday, co posted Q1 sales of $1.04 bln, above analysts' est of $1.02 bln - LSEG
** Co reiterated its annual sales forecast of $4.60 bln; analysts were expecting 2025 sales of $4.61 bln - LSEG
** J.P.Morgan analyst Robbie Marcus said the co has taken a "conservative approach" and expects to see "outperformance over the balance of the year"
** Co reports Q1 adj profit of 32 cents/share, compared with est of 33 cents/share - LSEG
** As of last close, stock down 9.7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.